Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
53,311,882
-
Total 13F shares
-
742,987
-
Share change
-
+742,987
-
Total reported value
-
$9,416,000
-
Price per share
-
$12.84
-
Number of holders
-
13
-
Value change
-
+$9,415,994
-
Number of buys
-
13
Institutional Holders of Aktis Oncology, Inc. - Common Stock, $0.0001 par value per share (AKTSQ) as of Q1 2017
As of 31 Mar 2017,
Aktis Oncology, Inc. - Common Stock, $0.0001 par value per share (AKTSQ) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
742,987 shares.
The largest 10 holders included
Herald Investment Management Ltd, Precept Management LLC, GOLDMAN SACHS GROUP INC, EAM Investors, LLC, MILLENNIUM MANAGEMENT LLC, D.A. DAVIDSON & CO., BOSTON FINANCIAL MANGEMENT LLC, Ascent Wealth Partners, LLC, MORGAN STANLEY, and Segantii Capital Management Ltd.
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.